Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis
AssigneeThe Scripps Research Institute
InventorsPaul Schimmel, Keisuke Wakasugi, Martin Friedlander
Life of this patent
Estimating the term…
Abstract
The invention provides a method for inhibiting ocular neovascularization in a patient. The method comprises administering to a patient an ocular neovascularization inhibiting amount of a water-soluble polypeptide selected from the group consisting of SEQ ID NO: 12, SEQ ID NO: 7, and an ocular neovascularization inhibiting fragment thereof, which includes at least one of amino acid residue signature sequences HVGH (SEQ ID NO:10) and KMSAS (SEQ ID NO:11). A method for assaying the angiogenesis inhibiting activity of a composition is also provided.
Claims17
A method for inhibiting ocular neovascularization in a patient, the method comprising administering to a patient an ocular neovascularization inhibiting amount of a water-soluble polypeptide selected from the group consisting of SEQ ID NO:
- 12, SEQ ID NO:
- 7, and an ocular neovascularization inhibiting fragment thereof, the fragment including at least one of amino acid residue signature sequences HVGH (SEQ ID NO:10) and KMSAS (SEQ ID NO:11).
A method for inhibiting ocular neovascularization in a patient, the method comprising intraocularly injecting into the eye of a patient an ocular neovascularization inhibiting amount of a water-soluble polypeptide consisting of SEQ ID NO:
- 12, or an ocular neovascularization inhibiting fragment thereof, the fragment including at least one of amino acid residue signature sequences HVGH (SEQ ID NO:10) and KMSAS (SEQ ID NO:11).
Dependencies are inferred from the claim text.